Status | Study |
Recruiting |
Study Name: Blinatumomab in Adult Patients With Minimal Residual Disease (MRD) of B-precursor Acute Lymphoblastic Leukemia Condition: ALL, Recurrent, Adult Date: 2017-03-13 Interventions: Drug: Blinatumomab Patients will receive blinatumomab at a |
Recruiting |
Study Name: Investigating Minimal Residual Disease in Autopreserved Ovarian Tissue in Cases of Neoplastic Pathology Condition: Neoplastic Pathology Autopreserved Ovarian Tissue Date: 2016-08-30 |
Recruiting |
Study Name: Validation of a Method to Search Residual Disease in Auto-cryopreserved Ovarian Tissues Condition: Neoplastic Pathology Minimal Residual Disease Date: 2016-08-30 |
Not yet recruiting |
Study Name: MRD-directed Therapy for Low-risk and Intermediate-risk AML. Condition: Acute Myeloid Leukemia Minimal Residual Disease Date: 2016-08-14 Interventions: Other: MRD-directed therapy The purpose of this study is to establish risk stratification based on cytog |
Recruiting |
Study Name: Assessment of Minimal Residual Disease (MRD) After Antineoplastic Treatment in Patients With AL Amyloidosis Condition: Amyloidosis Date: 2016-03-14 Interventions: Other: blood collection Other: bone marrow |
Completed |
Study Name: Prognostic Role of Minimal Residual Disease in Acute Myeloid Leukemia Condition: Acute Myeloid Leukemia Minimal Residual Disease Date: 2016-03-03 |
Recruiting |
Study Name: MRD-directed Donor Lymphocyte Infusion for Reduce of Relapse After Allo-HSCT Condition: Minimal Residual Disease Donor Lymphocyte Infusion Date: 2016-01-23 Interventions: Biological: donor lymphocyte infusion |
Recruiting |
Study Name: Intraoperative Intraperitoneal Chemoperfusion to Treat Peritoneal Minimal Residual Disease in Stage III Ovarian Cancer Condition: Ovarian Cancer Primary Peritoneal Cancer Date: 2015-09-23 Interventions: Procedure: Cytoreductive surgery |
Recruiting |
Study Name: Minimal Residual Disease as a Possible Predictive Factor for Relapse in Patients With AL Amyloidosis Condition: Amyloidosis Primary Amyloidosis Date: 2015-09-16 |
Recruiting |
Study Name: Study of Blinatumomab in Patients With B-cell Lineage Acute Lymphocytic Leukemia With Positive Minimal Residual Disease Condition: Leukemia Acute Lymphocytic Leukemia Date: 2015-05-26 Interventions: Drug: Blinatumomab In first in |